发明名称 Tissue targeted antigenic activation of the immune response to treat cancers
摘要 Disclosed are methods of treating cancers of a specific organ or tissue by administering a composition that is antigenically specific for one or more microbes that are pathogenic in the specific organ or tissue in which the cancer is situated. The formulations of the invention thereby facilitate activation of a treatment response to a cancer in a particular tissue or organ. The compositions may for example include killed or attenuated microbial pathogens, and may be administered at sites distant from the cancer, for example the skin. In some embodiments, microbial species of endogenous flora that are known to cause infection in the relevant organ or tissue may be used in the formulation of the antigenic compositions. In alternative embodiments, exogenous microbial pathogens that are known to cause infection in the relevant organ or tissue may be used in the formulation of the antigenic compositions. The administration of the immunogenic compositions may be repeated relatively frequently over a relatively long period of time. In embodiments for intradermal or subcutaneous injection, dosages may be adjusted so that injections reproduce a consistent visible delayed inflammatory immune reaction at the successive site or sites of administration.
申请公布号 NZ601232(A) 申请公布日期 2014.01.31
申请号 NZ20070601232 申请日期 2007.10.25
申请人 QU BIOLOGICS INC 发明人 GUNN HAROLD DAVID
分类号 A61K39/00;A61K39/02;A61K39/12;A61P35/00;A61P35/04;A61P37/04 主分类号 A61K39/00
代理机构 代理人
主权项
地址